Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Zinc showed no clear difference in progression to visual loss (loss of 3 or more lines on logMAR chart) compared with placebo (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Antioxidant multivitamin and mineral supplement showed no clear difference in progression to geographic atrophy compared with placebo or no treatment (moderate certainty).
Antioxidant multivitamin and mineral supplement probably leads to lower progression to visual loss (loss of 3 or more lines on logMAR chart) compared with placebo or no treatment (moderate certainty).
Antioxidant multivitamin and mineral supplement may leads to lower adverse effects compared with placebo or no treatment (low certainty).
The review found no eligible studies for this question.
Lutein with or without zeaxanthin showed no clear difference in progression to late AMD (neovascular AMD, geographic atrophy, or both) compared with placebo (low certainty).
Lutein with or without zeaxanthin showed no clear difference in progression to neovascular AMD compared with placebo (low certainty).
Any cranberry product probably leads to lower symptomatic, culture‐verified UTI Women with recurrent UTI compared with placebo or control (moderate certainty).
Any cranberry product showed no clear difference in symptomatic, culture‐verified UTI Elderly men and women in… compared with placebo or control (moderate certainty).
Any cranberry product probably leads to lower symptomatic, culture‐verified UTI Children compared with placebo or control (moderate certainty).
Any cranberry product showed no clear difference in symptomatic, culture‐verified UTI Adults with bladder emptying… compared with placebo or control (low certainty).
Any cranberry product may leads to lower symptomatic, culture‐verified UTI People with a susceptibility to a… compared with placebo or control (low certainty).
Any cranberry product showed no clear difference in gastrointestinal adverse events compared with placebo or control (moderate certainty).
Serenoa repens showed no clear difference in urologic symptom scoreMeasured by IPSS scores (range 0 to 35)Higher… compared with placebo or no intervention (high certainty).
Serenoa repens showed no clear difference in quality of lifeMeasured by IPSS‐QoL score (range 0 to 6) compared with placebo or no intervention (high certainty).
Serenoa repens showed no clear difference in adverse eventsCumulative incidence compared with placebo or no intervention (moderate certainty).